Dianna Howard

General Clinical Research Center

National Center for Research Resources · M01

Project lead · $88K · University of Kentucky

Bortezomib and Idarubicin in the Treatment of AML

National Cancer Institute · R21

Contact PI · $498.3K · University of Kentucky

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Principal investigator · Completed · Phase 2

Wake Forest University Health Sciences

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Principal investigator · Terminated · Phase 1, Phase 2

Biosuccess Biotech Co., Ltd.

Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML

Principal investigator · Completed · Phase 1

University of Kentucky

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Principal investigator · Recruiting

Wake Forest University Health Sciences